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In 2009, the influenza A (H1N1) virus spread rapidly around the world, causing the first pandemic of the 21st
Century. In 2010, there was a vaccination campaign against this new virus subtype to reduce the morbidity and
mortality of the disease in some countries, including Brazil. Herein, we describe the clinical and epidemiological
characteristics of patients under 19 years of age who were hospitalized with confirmed influenza A (H1N1) infection
in 2009 and 2010. We retrospectively reviewed files from the pediatric patients who were admitted to a university
hospital with real-time polymerase chain reaction (RT-PCR) confirmed influenza A (H1N1) infection in 2009 and
2010. There were 37 hospitalized patients with influenza A (H1N1) in 2009 and 2 in 2010. In 2009, many of the
hospitalized children had an underlying chronic disease and a lower median age than those not hospitalized. Of the
hospitalized patients, 78% had a chronic disease, primarily pneumopathy (48%). The main signs and symptoms of
influenza were fever (97%), cough (76%), and dyspnea (59%). Complications occurred in 81% of the patients. The
median length of hospitalization was five days; 27% of the patients required intensive care, and two died. In 2010,
two patients were hospitalized with influenza A (H1N1): one infant with adenovirus co-infection who had received
one previous H1N1 vaccine dose and presented with respiratory sequelae and a 2-month-old infant who had a
hospital-acquired infection. An impressive reduction in hospital admissions was observed in 2010 when the
vaccination campaign took place in Brazil.
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INTRODUCTION
In 2009, the world faced the emergence of a new strain of
influenza virus (1). The influenza A (H1N1) virus spread
rapidly, causing the first pandemic of the 21st Century (2).
In Brazil, the first confirmed case of infection with the new
virus was reported on May 7th, 2009 by the Brazilian health
minister (3). On July 16th, 2009, the sustained human
transmission of the virus in Brazil was declared, and the
mandatory reporting of each patient diagnosed with acute
respiratory distress syndrome caused by the influenza A
(H1N1) virus was established (4).
Several actions were taken to control the epidemic in
Brazil, including the establishment of hospital admission
criteria for suspected cases. Sa˜o Paulo Hospital was one of
the reference hospitals for such patients.
Beginning in March 2010, the pandemic influenza vaccine
was available in Brazil for the population groups who
presented with higher morbidity and mortality after H1N1
infection in 2009 and for healthcare professionals and native
Indians (5-7). In the pediatric age group, first children aged
six months to two years were vaccinated; vaccinations were
subsequently extended to all children under age five.
In the literature, studies have discussed the characteristics
of the pediatric patients who were admitted to the hospital
with influenza A (H1N1) infection. However, to our knowl-
edge, no published study has compared the 2009 and 2010
hospitalizations. In this study, we describe the clinical and
epidemiological characteristics of patients under age 19 who
were hospitalized with confirmed influenza A (H1N1)
infection in 2009 and 2010, the year that the vaccination
campaign against pandemic influenza began in Brazil.
METHODS
This study was conducted at Sa˜o Paulo Hospital, a
tertiary university hospital in Sa˜o Paulo, Brazil, with
pediatric wards, semi-intensive, and intensive care units
(ICU).
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This is a retrospective study of suspected cases of
influenza A (H1N1) infection reported to the disease control
surveillance system of our hospital. We selected patients
under 19 years and separated them into confirmed cases
admitted and confirmed cases not admitted to hospital. We
considered confirmed cases of influenza A (H1N1) those
with virus detection in nasopharyngeal and pharyngeal
swabs. Briefly, viral RNA was extracted using QIAamp
Viral RNA extraction kit (Qiagen, Germany) according to
manufacturer’s instructions. Influenza A (H1N1) detection
was performed at Adolfo Lutz Institute, a Brazilian
government laboratory, or at the Clinical Virology
Laboratory at the Federal University of Sa˜o Paulo using
the Real Time protocol published by the CDC on April 28,
2009 (8).
Data on gender, age, and comorbidities were collected
from all of the patients who were not admitted to the
hospital. Patients who were hospitalized for longer than
24 hours were assessed for demographic data, including a
review of clinical data described in the medical chart, such
as the unit to which the patient was admitted, early
symptoms, complications, major medical procedures, and
treatment. Vaccination records on influenza A (H1N1) were
also collected from the patients who were admitted in 2010.
We defined respiratory failure as dyspnea with hypox-
emia (oximetry less than 95% in ambient air) (9). Acute
respiratory distress syndrome was defined as fever, cough,
and dyspnea (4,7).
A suspected case of influenza A (H1N1) was defined as
febrile acute disease with cough or sore throat in the absence
of other diagnoses (5).
In the beginning of the pandemic, all influenza A (H1N1)
cases had to be reported. This rule was modified on July 16,
2009 (28th epidemiological week), when priority reporting
for laboratorial diagnosis and treatment was established for
patients presenting with severe acute respiratory distress
syndrome and those with associated risk factors (4).
The statistical analysis was performed with BioEstat 5.0
(published by the Institute for Sustainable Development of
Mamiraua´, Brazil). The Mann-Whitney U-test was used for
continuous variables, and the Chi-squared test was used
for categorical variables. Statistical significance was set at
p,0.05.
This study was approved by the Ethics Committee at the
Federal University of Sa˜o Paulo, Brazil.
RESULTS
Year: 2009
There were 282 suspected cases of pandemic influenza A
(H1N1) in children and adolescents under age 19 in our
hospital, and 37 patients were hospitalized with confirmed
infection. Three patients had already been hospitalized for
other reasons when they became infected. The majority of
admissions occurred in the 30th epidemiological week
(Figure 1).
Among those patients with confirmed pandemic influenza
A (H1N1), 41 were not hospitalized. The hospital-admitted
group had more chronic diseases (29/37 versus 13/41; Chi-
squared test, p,0.001) and a lower median age (4.9 y versus
10.4 y; Mann-Whitney U-test, p,0.001) than the non-
admitted group. Also, 65% of the admitted children versus
95% of the non-admitted were over age 2 (Chi-squared test,
p,0.001). Table 1 shows the results.
Of the patients with confirmed influenza A (H1N1), 36
were admitted to the hospital on the same day they arrived
in the emergency room. The median time between the first
symptoms and the hospital admission was four days (range,
1 to 10). Four days was also the median time between the
first symptoms and the collection of a nasopharynx swab
(range, 1 to 10). The median hospital stay was five days. For
treatment, 34/37 (91.9%) patients received oseltamivir, and
24/34 (70.6%) started oseltamivir within 48 hours of the first
symptoms.
The major signs and symptoms presented at admission
were fever (97%), cough (76%), dyspnea (59%), decreased
food intake (35%), rhinorrhea (32%), and hypoactivity
(32%).
A total of 29 of the 37 hospitalized patients (78%) had at
least one underlying medical condition. Pneumopathy was
the most commonly observed condition (14/29; 48%),
followed by neuropathy (8/29; 28%), hemoglobinopathy
(5/29; 17%), immunosuppression (4/29; 14%), and heart
disease (3/29; 10%). Nine patients had more than one
disease.
Complications occurred in 81% (30/37) of the patients,
respiratory failure in 51%, pneumonia in 49%, and sepsis in
16%. Two (5.4%) patients had reversed cardiopulmonary
arrest; one (2.7%) had rejection of a transplanted kidney; one
(2.7%) had acute metabolic acidosis at the onset of diabetes
mellitus type 1, and two (5.4%) died. Furthermore, 73% of
patients required oxygen supplementation, 19% required
mechanical ventilation, and 62% received antibiotics.
Of the 37 patients hospitalized with confirmed infection,
ten were admitted to the ICU. The median age in this group
was 5.1 years; 50% were male, and 90% had some under-
lying condition. All of the patients presented with compli-
cations (nine had acute respiratory failure, nine had
pneumonia, one had hypoxia), and 70% required mechan-
ical ventilation. All of the patients admitted to the ICU
received oseltamivir. The median ICU stay was 3.5 days
(range 2–81 days).
Two children died in 2009 from influenza A (H1N1)
infection in our hospital; one child was a 4-year-old female
who had intermittent asthma. The symptoms had started
three days prior to her hospital admission with cough, fever,
diarrhea, and sore throat. The child was admitted to the ICU
with acute respiratory failure on the day she arrived at the
hospital, and mechanical ventilation was required. She
developed pneumonia, septic shock, and pulmonary
hemorrhage and died on the second day of hospitalization.
Figure 1 - The number of patients with confirmed influenza A
(H1N1) per epidemiological week at Sa˜o Paulo Hospital in 2009,
separated by hospital-admitted group and non-hospital-
admitted group.
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The other deceased patient was a 16-year-old girl with
Down’s syndrome, heart disease, diabetes mellitus,
hypothyroidism, and hypertension. The symptoms had
started four days prior to admission with fever, dyspnea,
diarrhea, vomiting, and abdominal pain. The patient was
admitted to the ICU on the second day of hospitalization
and developed acute respiratory failure, pneumonia, hepa-
titis, heart failure, acute renal failure and shock; she died 14
days after hospital admission.
Year: 2010
In 2010, there were 69 reported cases and only two
confirmed cases of influenza A (H1N1) infections at Sa˜o
Paulo Hospital. Both of the confirmed infections required
hospitalization. The first case was a 9-month-old, previously
healthy boy with coughing and rhinorrhea two weeks prior
to his hospitalization; the symptoms had worsened five
days prior to admission; he developed fever, hypoactivity,
and dyspnea. The boy had received one previous H1N1
vaccine dose 13 days before the first symptoms appeared.
Oral antibiotics, oral corticosteroids and inhalation with
saline solution had already been administered for four days
before the hospital admission. Acute respiratory failure and
bilateral pneumonia were diagnosed in the emergency
room, and the child was placed on mechanical ventilation
for 13 days and treated with broad-spectrum antibiotics and
two cycles of oseltamivir. He developed subglottic stenosis
and was discharged with a tracheostomy after 47 days of
hospitalization. A nasopharynx swab was collected on the
13th day of hospitalization. Both influenza A (H1N1) and
adenovirus were detected.
The other patient was a 2-month-old boy with encepha-
locele and sepsis; he was admitted to the same ICU as the
other child diagnosed with influenza A (H1N1) and was
treated with oseltamivir and noninvasive oxygen therapy.
He was discharged without any respiratory sequelae.
DISCUSSION
In 2009, we witnessed a pandemic of the previously
unknown subtype influenza A (H1N1) virus (10). The first
confirmed cases in our hospital were in the 22nd epidemio-
logical week, and the majority of the admissions and
confirmed cases occurred during the 30th epidemiological
week. In Brazil, the peak confirmation rate of cases was seen
in the 31st epidemiological week (7).
During the pandemic, changes were made to the report-
ing and selection criteria for laboratorial diagnosis. In the
28th epidemiological week, reporting was required only for
the cases with severe acute respiratory distress syndrome or
those with risk factors for worse outcomes (4). At our
hospital, the majority of hospitalizations occurred after this
date.
In our study, the admitted children were younger than
the non-admitted children. In Brazil, the age groups that
had more frequent acute respiratory distress syndrome
were children under age 2 and adults between the ages of 20
and 29 years (7,11).
In concordance with other studies, the children who were
admitted to our hospital with influenza A (H1N1) infection
had a high prevalence of chronic disease, with a predomi-
nance of pneumopathy (5,12-17). However, we must
consider that the high percentage found here might
represent a bias because Sa˜o Paulo Hospital is a tertiary
hospital.
In this study, there were two deaths, two reversed
cardiopulmonary arrests, one rejection of a transplanted
kidney and an acute metabolic acidosis at the onset of
diabetes mellitus type 1, all of which were critical cases. A
recent Brazilian study demonstrated a more severe course of
the disease in children infected with the H1N1 virus than in
children with flu-like symptoms who received negative
rapid tests for H1N1 (18).
As observed in the United States (12), Argentina (15),
Canada (17), and in another Brazilian study (18), most
patients who were hospitalized with influenza A (H1N1)
had complications, and many needed intensive care, despite
immediate hospitalization from the emergency room and
prompt oseltamivir initiation. Seventy-one percent of the
hospitalized patients in our study started this medication
more than 48 hours after the symptoms began. This delay
could have contributed to a worsening of their clinical
condition.
In this study, 27% of the 37 children who were
hospitalized were admitted to the ICU, and 78% had some
underlying disease. Likewise, among the first 272 patients
hospitalized with influenza A (H1N1) reported in the
United States, 25% were admitted to an ICU, and 73% had
at least one underlying medical condition (12).
During annual outbreaks of seasonal influenza, most
patients who require hospitalization are at the extremes of
age distribution. There are also a greater number of
hospitalizations in patients with chronic diseases, such as
diabetes, cardiovascular disease, neurological disease, and
pulmonary disease (including asthma) (12,19,20). A sig-
nificant number of hospitalizations are caused by influenza
every year (19-21).
Despite a stable total number of hospital admissions in all
pediatric units at our hospital in 2009 and 2010, there was a
reduction in the hospital admissions of confirmed pediatric
influenza A (H1N1) patients after the vaccination campaign
in 2010. This result is in accordance with other data from our
country (22).
The total number of influenza A (H1N1) vaccine doses
administered in Brazil was 89,580,203. The vaccination
coverage for children under age 2 was 100% (5,580,671
vaccine doses) and 60% for the 2 to 4 year-old age group,
with 5,202,438 vaccine doses given (23).
Here, we have described influenza A (H1N1) pediatric
cases admitted to a tertiary hospital in Sa˜o Paulo, Brazil over
two consecutive years. The striking decrease in the number
of cases from 2009 to 2010 is likely an effect of the massive
Table 1 - Characteristics of patients infected with influenza A (H1N1) in 2009.
2009 Admitted Patients Non-Admitted Patients p-value
Male gender 19/37 (51%) 23/41 (56%) 0.6
Median age in years (range)
Age .2 years
4.9 (0.2 - 16.9)
24/37 (65%)
10.4 (0.4 – 18.9)
39/41 (95%)
,0.001
,0.001
Underlying conditions 29/37 (78%) 13/41 (32%) ,0.001
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influenza A (H1N1) vaccination campaign in Brazil in 2010,
along with the immunity acquired by the population
because of the intense viral circulation.
AUTHOR CONTRIBUTIONS
Marcos AC and Pelissoni FA participated in data collection, data analysis
and manuscript writing. Cunegundes KS participated in data analysis.
Abramczyk ML and Sanches NA participated in data collection. Bellei NC
participated in PCR laboratory analysis and data collection. Moraes-Pinto
MI participated in data analysis, writing and review of the manuscript.
REFERENCES
1. Centers for Disease Control and Prevention. Swine influenza A (H1N1)
infection in two children – Southern California, March-April 2009.
MMWR Morb Mortal Wkl Rep. 2009;58(15):400-402. Available at
,http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5815a5.htm.
2. World Health Organization. Media Centre. World now at the start of
2009 influenza pandemic. Available at ,http://www.who.int/media-
centre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/
index.html..
3. Brazil–Ministe´rio da Sau´de. Assessoria de Comunicac¸a˜o Social – Divisa˜o
de Imprensa. Pronunciamento do ministro da Sau´de, Jose´ Gomes
Tempora˜o, Brası´lia, 7 de maio de 2009. Available at,http://portal.saude.
gov.br/portal/arquivos/pdf/influensa.pdf (27 June 2011, date last
accessed.
4. Brazil–Ministe´rio da Sau´de. Secretaria de Vigilaˆncia em Sau´de, July 2009.
Informe epidemiolo´gico, influenza A (H1N1). Available at ,http://
portal.saude.gov.br/portal/arquivos/pdf/informe_influenza_a_h1n1_31_
07_2009.pdf.
5. Centro de Vigilaˆncia Epidemiolo´gica Prof. Alexandre Vranjac’’.
Coordenadoria de Controle de Doenc¸as. Secretaria de Estado da
Sau´de. Sa˜o Paulo, SP, Brasil. Informe Te´cnico. ‘‘Influenza A/H1N1:
update’’. BEPA, Bol Epidemiol Paul. 2009;6(69):19-28. Available at
,ftp://ftp.cve.saude.sp.gov.br/doc_tec/outros/bol_bepa6909.pdf..
6. Centro de Vigilaˆncia Epidemiolo´gica ‘‘Prof. Alexandre Vranjac’’.
Coordenadoria de Controle de Doenc¸as. Divisa˜o de Doenc¸as de
Transmissa˜o Respirato´ria. Secretaria de Estado da Sau´de. Sa˜o Paulo, SP,
Brasil. Atualizac¸a˜o. ‘‘Epidemiological Report on Pandemic Influenza H1N1
2009, 2010 – April’’. - BEPA, Bol Epidemiol Paul. 2010;7(76):20-24. Available
at ,ftp://ftp.cve.saude.sp.gov.br/doc_tec/outros/bepa7610.pdf..
7. Centro de Vigilaˆncia Epidemiolo´gica‘‘Prof. Alexandre Vranjac’’. Instituto
Adolfo Lutz. Coordenadoria de Controle de Doenc¸as. Secretaria de
Estado da Sau´ de. Sa˜ o Paulo, SP, Brasil. Informe Te´ cnico.
‘‘Influenza A (H1N1) in the State of Sa˜o Paulo, public health emergency
of international concern articulated response, with emphasis on reducing
morbidity and mortality associated with pandemic.’’ BEPA, Bol
Epidemiol Paul. 2010;7(84):12-17. Available at ,http://periodicos.
ses.sp.bvs.br/pdf/bepa/v7n84/v7n84a02.pdf..
8. Centers for Disease Control and Prevention – CDC. CDC Protocol for
realtime RTPCR for influenza A (H1N1). Available at ,http://www.who.
int/csr/resources/publications/swineflu/CDCRealtimeRTPCR_SwineH1
Assay-2009_20090430.pdf..
9. Piva JP, Garcia PC, Santana JC, Barreto SS. Respiratory failure in
children. J Pediatr (Rio J). 1998;74(1):99-112, http://dx.doi.org/10.2223/
JPED.491.
10. Centers for Disease Control and Prevention. The 2009 H1N1 Pandemic:
Summary Highlights, April 2009 - April 2010. Available at ,http://
www.cdc.gov/h1n1flu/cdcresponse.htm..
11. Toufen C Jr, Costa EL, Hirota AS, Li HY, Amato MB, Carvalho CR.
Follow-up after acute respiratory distress syndrome caused by influenza
a (H1N1) virus infection. Clinics. 2011;66(6):933-7, http://dx.doi.org/
10.1590/S1807-59322011000600002.
12. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al.
Hospitalized patients with 2009 H1N1 influenza in the United States,
April-June 2009. N Engl J Med. 2009;361(20):1935-44, http://dx.doi.org/
10.1056/NEJMoa0906695.
13. Kumar S, Havens PL, Chusid MJ, Willoughby RE Jr, Simpson P,
Henrickson KJ. Clinical and Epidemiologic Characteristics of Children
Hospitalized With 2009 Pandemic H1N1 Influenza A Infection. Pediatr
Infect Dis J. 2010;29(7):591-4.
14. Lee HY, Wu CT, Lin TY, Chiu CH. 2009 Pandemic influenza H1N1:
paediatric perspectives. Ann Acad Med Singapore. 2010;39(4):333-3.
15. Libster R, Bugna J, Coviello S, Hijano DR, Dunaiewsky M, Reynoso N,
et al. Pediatric hospitalizations associated with 2009 pandemic influenza
A (H1N1) in Argentina. N Engl J Med. 2010;362(1):45-55, http://
dx.doi.org/10.1056/NEJMoa0907673.
16. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors
associated with death or hospitalization due to pandemic 2009 influenza
A(H1N1) infection in California. JAMA. 2009;302(17):1896-902, http://
dx.doi.org/10.1001/jama.2009.1583.
17. O’Riordan S, Barton M, Yau Y, Read SE, Allen U, Tran D. Risk factors
and outcomes among children admitted to hospital with pandemic
H1N1 influenza. CMAJ. 2010;182(1):39-44.
18. Tresoldi AT, Pereira RM, Fraga AM, Romaneli MT, Omae CC, Baracat
EC, et al. Clinical Features and Outcome of Children and Adolescents
Hospitalized with Influenza A (H1N1) Virus Infection Compared with
Flu-Like Symptoms and Negative Rapid Tests for Influenza A (H1N1)
Admitted in the Same Period of Time. J Trop Pediatr. 2011;57(6):481-3,
http://dx.doi.org/10.1093/tropej/fmr023.
19. Dawood FS, Fiore A, Kamimoto L, Bramley A, Reingold A, Gershman K,
et al. Emerging Infections Program Network. Burden of seasonal
influenza hospitalization in children, United States, 2003 to
2008. J Pediatr. 2010;157(5):808-14.
20. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ,
et al. Influenza-associated hospitalizations in the United States. JAMA.
2004;292(11):1333-40, http://dx.doi.org/10.1001/jama.292.11.1333.
21. Brooks WA, Goswami D, Rahman M, Nahar K, Fry AM, Balish A, et al.
Influenza is a major contributor to childhood pneumonia in a tropical
developing country. Pediatr Infect Dis J. 2010;29(3):216-21.
22. Centro de Vigilaˆncia Epidemiolo´gica ‘‘Prof . Alexandre Vranjac’’.
Coordenadoria de Controle de Doenc¸as. Divisa˜o de Doenc¸as de
Transmissa˜o Respirato´ria. Secretaria de Estado da Sau´de. Sa˜o Paulo, SP,
Brasil. Atualizac¸a˜o. ‘‘Epidemiologic report pandemic influenza H1N1 2009 –
July, 2010.’’ BEPA, Bol Epidemiol Paul. 2010;7(79):23-26. Available at,ftp://
ftp.cve.saude.sp.gov.br/doc_tec/outros/bepa79_influa.pdf..
23. Brazil - Ministe´rio da Sau´de. DATASUS. Vacinoˆmetro. http://pni.datasus.
gov.br/consulta_h1n1_10_selecao.asp?naofechar=N&enviar=ok&grupo=
todos&faixa=todos&sel=vacinometro (27 June 2011, date last accessed).
Pediatric H1N1 infection in 2009/2010
Marcos AC et al.
CLINICS 2012;67(10):1215-1218
1218
